Nukkleus Inc. (NASDAQ:DFNS) Short Interest Up 159.3% in June

Nukkleus Inc. (NASDAQ:DFNS) was the target of a significant growth in short interest during the month of June. As of June 15th, there was short interest totaling 12,709,157 shares, a growth of 159.3% from the May 31st total of 4,901,184 shares. Based on an average daily trading volume, of 38,610,141 shares, the short-interest ratio is presently 0.3 days. Approximately 27.1% of the shares of the company are short sold.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Nukkleus in a research report on Thursday, June 18th. Wall Street Zen lowered shares of Nukkleus from a “hold” rating to a “sell” rating in a research note on Saturday, April 18th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.

Institutional Investors Weigh In On Nukkleus

Institutional investors have recently made changes to their positions in the stock. BNP Paribas Financial Markets bought a new stake in shares of Nukkleus during the 2nd quarter valued at $56,000. State Street Corp boosted its stake in Nukkleus by 70.7% in the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after purchasing an additional 7,400 shares during the period. Price T Rowe Associates Inc. MD purchased a new position in Nukkleus during the 4th quarter valued at about $57,000. GM Advisory Group LLC bought a new stake in shares of Nukkleus during the fourth quarter valued at about $56,000. Finally, Millennium Management LLC bought a new stake in shares of Nukkleus during the fourth quarter valued at about $60,000. Hedge funds and other institutional investors own 12.47% of the company’s stock.

Nukkleus Stock Performance

NASDAQ:DFNS traded down $0.01 on Tuesday, reaching $0.17. 3,542,212 shares of the company’s stock were exchanged, compared to its average volume of 6,123,789. The firm has a market cap of $15.66 million, a price-to-earnings ratio of -0.06 and a beta of -6.00. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.25 and a quick ratio of 0.21. The stock has a fifty day simple moving average of $0.37 and a 200-day simple moving average of $1.72. Nukkleus has a 52 week low of $0.16 and a 52 week high of $15.59.

Nukkleus (NASDAQ:DFNS) last announced its quarterly earnings results on Wednesday, May 20th. The company reported ($1.14) EPS for the quarter. The company had revenue of $3.65 million for the quarter. As a group, sell-side analysts predict that Nukkleus will post -0.99 earnings per share for the current year.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.